Diabetes, Obesity & Metabolism
Dapagliflozin Alters Plasma Metabolome in Patients With Type 1 Diabetes During Ketosis
Non-randomised trial in 17 peopleDapagliflozin
Papers by Kai E. Jones
2 results
- ADA Scientific Sessions 2025 Abstract
Dapagliflozin Alters TCA Cycle Activation during Insulin Withdrawal in T1D Patients
Trial in peopleInterventions